Responses
Clinical/translational cancer immunotherapy
Original research
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.